CTOs on the Move


 
Reboot Inc. is a technology solution provider that offers IT services and support to businesses in the Indianapolis area. They provide a proprietary, documented, and proven system that reduces computer and network problems by 200%, and increases produc...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.rebootinc.com
  • 11611, North Meridian Street
    Carmel, IN USA 46032
  • Phone: 317.225.4476

Executives

Name Title Contact Details

Similar Companies

Redpoint Cybersecurity

The official Twitter page of Redpoint Cybersecurity

Screening Eagle Technologies

Screening Eagle Technologies provides a technology platform for intelligent inspection of the built environment. The company was created through the merger of Dreamlab in Singapore and Proceq in Switzerland with a mission to protect the built world with software, sensors and data. Screening Eagle`s full-stack inspection solution combines intuitive software and powerful portable sensors to deliver reliable data for construction and asset maintenance decisions. Powered by data from intelligent and autonomous inspection, Screening Eagle is on a steep growth path to realizing its vision of predictive healthcare that extends asset life and increases long-term value for asset owners.

Fusionware

Fusionware is the leading cloud-based produce supply chain management platform designed to help you manage, optimize and grow your business.

Zola

Zola is an innovative Registry that is transforming how couples and guests share, buy, and ship wedding gifts. Driven by the belief that today`s engaged duos should have access to offerings that reflect their current tastes on a platform that can keep up with their daily needs, we are reinventing old systems and providing easy to build, easy to manage, and easy to share online registries full of products people actually want.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.